期刊文献+

134例宫颈上皮内瘤变患者HPV分型检测结果分析

Study on the types of human papillomavirus of 135 cases in cervical intraepitheliai neoplasia and cervical carcinoma
原文传递
导出
摘要 目的探讨宫颈上皮内瘤变(CIN)中不同类型人乳头瘤病毒(HPV)的感染及分型情况。方法回顾性研究北京军区总医院妇科门诊134例已经确诊的CIN患者,采用凯普的核酸分子快速导流杂交基因芯片技术对HPV进行分型。结果 1.各级别CIN以HPV高危亚型单一或者多重感染为主;2.在HPV阳性的101例患者中,单一感染者73例(72.28%),双重感染者24例(23.76%),三重感染者3例(2.97%),四重感染者1例(0.99%);3.HPV-16、58感染率最高,分别为30.83%,24.06%。结论 HPV感染以高危型和多重感染为主;随CIN级别的增高,HPV阳性率也是增高的;HPV-16亚型的感染率最高。 Objective: To study the infection condition of different types of Human papiUoma virus in cervical intraepithelial neoplasia (CIN). Methods: A total of 134 gynecological outpatients in The Military General Hospital of Beijing who were confirmed to have CIN were studied, The HybriMax were used to detect HPV genotypes. Results: 1. All levels of CIN is main infected with single or multiple high risk HPV genotypes. 2. In 102 HPV positive patients, single infected patients is 74 cases (72. 28% ), double infected patients is 24 cases (23, 76% ), triple infected patients is 3 cases (2. 97% ), quadruple patients infected is 1 case (0. 99% ) ; 3. The infected rate of HPV - 16, 58 is the hightest, 30. 83% and 24. 06% respectively. Conclusion: The main infected HPV is the high risk and mul- tiple genotypes, As the CIN types increaseing, the positive HPV is increasing too. The infection of HPV - 16 types is the highest.
出处 《中国优生与遗传杂志》 2012年第11期77-79,共3页 Chinese Journal of Birth Health & Heredity
关键词 人乳头瘤病毒 宫颈上皮内瘤变 Human papilloma virus Cervical intraepithelial neoplasia
  • 相关文献

参考文献11

  • 1钱德英.重视宫颈癌前病变筛查的质量管理控制[J].中国实用妇科与产科杂志,2007,23(7):497-498. 被引量:102
  • 2Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologie natural history and clinical management of Human Papillomavirus (HPV) Disease : a critical and systematic review of the literature in the development of an HPV dynamic transmission model [ J ]. BMC Infect Dis, 2009,29 ( 9 ) : 119.
  • 3游珂,耿力,郭艳利,乔杰,沈晓野,姚燕君,范晓红,司胜丹,白丽.高危型人乳头瘤病毒以及病毒载量检测在诊断宫颈上皮内瘤变Ⅱ级及以上病变中的应用[J].中国微创外科杂志,2007,7(11):1096-1098. 被引量:9
  • 4Liu X, Zhang S, Ruan Q, et al. Prevalence and type distribution of human papillomavirus in women with cervicallesions in Liaoning Prov- ince, China[ J]. Int J Gynecol Cancer, 2010 Jan, 20( 1 ): 147 - 153.
  • 5Munoz N, Bosch FX,de Sanjos6 S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer [ J ]. N Engl J Med,2003 Feb, 348 (6) : 518 - 27.
  • 6Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guide- lines for the management of women with abnormal cervical cancer screening tests [ J ]. Am J Obstet Gyaecol, 2007 Oct, 197 (g) : 346 - 55.
  • 7Shihai Huang, Brian Erickson, Ning Tang,et al. Clinical perform- ance of Abbott Real Time High Risk HPV test for detection of high - grade cervical intraepithelial neoplasia in women with abnormal cytol- ogy[ J]. Journal of Clinical Virology 45 ,S1 (2009) : S19 - $23.
  • 8Zoltan Hernadi, Laszlo Gazdag, Krisztina Szoke, et al. Duration of HPV - associated risk for high - grade cervical intraepithelial neopla- sial J]. European Journal of Obstetrics & Gynecology and Reproduc- tive Biology,2006,125:114 - 119.
  • 9Kai - Erik Uleberg, Cecilie Ane Munk, Cato Brede, et al. Discrimi- nation of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies [ J]. Proteome Science,2011,9: 36 - 38.
  • 10Lutz Gissmann. HPV Vaccines : Preclinical Development [ J ]. Ar- chives of Medical Research, 2009.40:466 - 470.

二级参考文献18

  • 1张洁文,王建捷,蔺莉,朱玉凤,殷秀琴.高频电波刀电圈切除术治疗宫颈高危型人乳头瘤病毒感染的效果[J].中国微创外科杂志,2007,7(3):225-227. 被引量:11
  • 2Bulkmans NW, Berkhof J, Bulk S, et al. High-risk HPV typespecific clearance rates in cervical screening[ J]. Br J Cancer, 2007,96 : 1419-1424.
  • 3Hummer M, Schiffman M, Castle PE, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous intraepithelial lesion[ J]. J Infect Dis, 2007,95:1582-1589.
  • 4Aerssens A, Claeys P, Garcia A, et al. Natural history and clearance of HPV after treatment of precancerous cervical lesions [ J]. Histopathology,2008,52:381-386.
  • 5Soutter WP, de Barros Lopes A, Fcetcher A, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia [J]. Lancet,1997, 349(9057):978-980.
  • 6Elfgren K, Jacobs M, Walboomers JM, et al. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia [ J ]. Obstet Gynecol, 2002,100:965-971.
  • 7Debarge HV, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions[ J]. Gynecol Oneol, 2003,90(3) : 587-592.
  • 8Aerssens A, Claeys P, Beerens E, et al. Predition of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia[ J]. Cytopathology, 2009,20( 1 ) :27-35.
  • 9Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden : Globocan 2000. Int J Cancer,2001,94 : 153 - 156.
  • 10Siemens FC, Boon ME, Kuypers JC, et al. Population-based cervical screening with a 5-year interval in the Netherlands. Stabilization of the incidence of squamous cell carcinoma and its precursor lesions in the screened population. Acta Cytol, 2004,48 ( 3 ) : 348 - 354.

共引文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部